EU in Advanced Talks With Johnson & Johnson on Covid-19 Vaccine Deal

Kamis, 18 Juni 2020 | 17:47 WIB
EU in Advanced Talks With Johnson & Johnson on Covid-19 Vaccine Deal
[ILUSTRASI. Small bottles labeled with a 'Vaccine COVID-19' sticker and a medical syringe are seen in this illustration taken taken April 10, 2020. REUTERS/Dado Ruvic/Illustration]
Reporter: Sumber: Reuters | Editor: Narita Indrastiti

KONTAN.CO.ID - BRUSSELS (Reuters). The European Commission is in advanced talks with pharmaceutical giant Johnson & Johnson to reserve or buy up-front doses of its COVID-19 vaccine under development, two officials familiar with the talks told Reuters.

The move would be the first arranged by the European Union executive since it was mandated last week by the 27 EU national governments to use an emergency fund with more than 2 billion euros ($2.3 billion) available to reach advance purchase or call-option deals with up to six vaccine makers.

The Commission’s deal with the U.S. firm Johnson & Johnson is “in the pipeline”, a top health official from an EU member state said, asking to remain anonymous as was mentioning confidential discussions about vaccines between the EU executive and EU governments.

A second EU source said the Commission had a call with Johnson & Johnson on Tuesday over the possible agreement on its potential vaccine.

A Commission spokesman had no comment. Johnson & Johnson was not immediately available for comment outside U.S. business hours.

It was unclear whether any deal would involve an advance purchase of the vaccine in testing, or an option to buy it.

Johnson & Johnson plans next month to start human clinical trials for its experimental vaccine against the highly contagious coronavirus, which has infected more than 8.36 million people worldwide, with 447,985 deaths.

Germany, France, Italy and the Netherlands said last week they had acquired 400 million potential vaccine doses, in principle available to all member states, from British drugmaker AstraZeneca, which is developing a COVID-19 shot in conjunction with Oxford University.

AstraZeneca signed a similar deal in May with the United States.

The health official from an EU state said the EU deal with Johnson & Johnson could be announced as early as next week, but cautioned that it might take a little longer to finalise, and there were still chances it might not be struck at all.

EU decision-making procedures pose a sticking point for the potential deal, with member states still in talks over the establishment of a steering board for vaccine negotiations with drugmakers, officials told Reuters.

They said that under a draft plan devised by the EU Commission, which is still to be approved by EU governments, a green light from just four member states would be enough to start formal EU talks with a drugmaker.

But, underlining the urgency of securing a vaccine for the EU’s 450 million population, the Commission had already begun talks with Johnson & Johnson even before the steering board has been agreed.

By buying vaccines under development, the EU risks acquiring shots that may eventually prove unsuccessful against COVID-19.

But the risk is justified by the need to secure enough doses for the EU population in the global race for an effective vaccine, EU officials say.

Bagikan

Berita Terbaru

Berhasil Lalui Fase Transformasi, Kinerja Darma Henwa (DEWA) Diprediksi Terus Melaju
| Minggu, 01 Juni 2025 | 15:47 WIB

Berhasil Lalui Fase Transformasi, Kinerja Darma Henwa (DEWA) Diprediksi Terus Melaju

Laba bersih PT Darma Henwa Tbk (DEWA) diprediksi bakal terus tumbuh positif, setidaknya hingga tahun 2026.

Saham-Saham Grup Barito Top Leaders IHSG Mei 2025, Saham Sejuta Umat Jadi Top Laggard
| Minggu, 01 Juni 2025 | 13:46 WIB

Saham-Saham Grup Barito Top Leaders IHSG Mei 2025, Saham Sejuta Umat Jadi Top Laggard

IHSG ditutup pada 7.175,82 pada perdagangan terakhir, Rabu (28/5) ketimbang akhir April 2025 yang ada di 6.766,79.

Profit 29,64% Setahun, Harga Emas Antam Hari Ini Bergeming (1 Juni 2025)
| Minggu, 01 Juni 2025 | 09:05 WIB

Profit 29,64% Setahun, Harga Emas Antam Hari Ini Bergeming (1 Juni 2025)

Harga emas Antam hari ini (31 Mei 2025) 1.888.000 per gram. Di atas kertas pembeli setahun lalu bisa untung 29,64% jika menjual hari ini.

Ada Perombakan Indeks Kehati, Bagaimana Dampaknya Terhadap Saham ESG?
| Minggu, 01 Juni 2025 | 06:19 WIB

Ada Perombakan Indeks Kehati, Bagaimana Dampaknya Terhadap Saham ESG?

Perubahan saham pilihan Indeks Sri-Kehati, ESGS-Kehati, dan ESGQ-Kehati bisa jadi momentum mengejar untung jangka pendek

Upaya Perbankan Menjaring Para Pensiunan
| Minggu, 01 Juni 2025 | 04:14 WIB

Upaya Perbankan Menjaring Para Pensiunan

Untuk mendukung kebutuhan finansial, bank menyediakan layanan tabungan pensiunan yang disesuaikan dengan usia.   

Jembatan Pembeli dengan Produsen Manufaktur
| Minggu, 01 Juni 2025 | 04:14 WIB

Jembatan Pembeli dengan Produsen Manufaktur

Pelaku di industri manufaktur bisa semakin menggeliat dengan bantuan platform yang bisa carikan pasar. Yuk, simak layanannya.

 Tanpa Modal Jumbo, Bisa Beli Obligasi di Pasar Sekunder
| Minggu, 01 Juni 2025 | 04:13 WIB

Tanpa Modal Jumbo, Bisa Beli Obligasi di Pasar Sekunder

Investor ritel bisa ikut beli obligasi di pasar sekunder dengan modal Rp 1 jutaan. Simak caranya!    

Stimulus Tidak Cukup
| Minggu, 01 Juni 2025 | 04:13 WIB

Stimulus Tidak Cukup

​ Daya beli masyarakat masih lunglai. Padahal, konsumsi masyarakat merupakan lokomotif utama pertumbuhan ekonomi negara kita.

Bahagia dan Tetap Mengeduk Cuan di Usia Pensiun
| Minggu, 01 Juni 2025 | 04:13 WIB

Bahagia dan Tetap Mengeduk Cuan di Usia Pensiun

Memasuki masa pensiun, bukan berarti seseorang tak bisa lagi mengeduk cuan. Dengan perencanaan matang, ada banyak usaha yang bisa dilakukan.

Tak Lagi Mulai Dari Nol, SPBU Swasta Merangsek Pasar
| Minggu, 01 Juni 2025 | 04:13 WIB

Tak Lagi Mulai Dari Nol, SPBU Swasta Merangsek Pasar

Bisnis SPBU semakin ramai. Persaingan SPBU pelat merah dan swasta kian kentara terutama di kota besar. Sejauh mana pelua

INDEKS BERITA

Terpopuler